HIGHLIGHTS
- who: Giovanni Palladini from the (UNIVERSITY) have published the Article: The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and, in the Journal: (JOURNAL) of 27/Dec/2022
- what: One of the study aims was to investigate potential differences between the cohorts of patients who initiated first-line treatment in 2004-2010 (pre2010) and 2011-2018 (post-2010), to depict changes in disease management secondary to the wider introduction of bortezomib-based regimens after 2010, especially of bortezomib, cyclophosphamide, and dexamethasone (VCD), in the everyday clinical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.